Progress in Lactate Metabolism and Its Regulation via Small Molecule Drugs
Molecules · 29.11.2024 · 29 (23) · 5656
DOI: 10.3390/molecules29235656 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 29.11.2024. Verfasst von Jin Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China. Hauptthemen laut MEDLINE: Lactic Acid. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 171 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Provincial Natural Science Foundation of China, Key Discipline Project on Chinese Pharmacology of Hunan University of Chinese Medicine, Hunan University of Chinese Medicine First-class Disciple Construction Project of Chinese Material Medical (China).
Abstract (Originalsprache)
Lactate, once viewed as a byproduct of glycolysis and a metabolic “waste”, is now recognized as an energy-providing substrate and a signaling molecule that modulates cellular functions under pathological conditions. The discovery of histone lactylation in 2019 marked a paradigm shift, with subsequent studies revealing that lactate can undergo lactylation with both histone and non-histone proteins, implicating it in the pathogenesis of various diseases, including cancer, liver fibrosis, sepsis, ischemic stroke, and acute kidney injury. Aberrant lactate metabolism is associated with disease onset, and its levels can predict disease outcomes. Targeting lactate production, transport, and lactylation may offer therapeutic potential for multiple diseases, yet a systematic summary of the small molecules modulating lactate and its metabolism in various diseases is lacking. This review outlines the sources and clearance of lactate, as well as its roles in cancer, liver fibrosis, sepsis, ischemic stroke, myocardial infarction, and acute kidney injury, and summarizes the effects of small molecules on lactate regulation. It aims to provide a reference and direction for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Förderung
- Hunan Provincial Natural Science Foundation of China
- Key Discipline Project on Chinese Pharmacology of Hunan University of Chinese Medicine
- Hunan University of Chinese Medicine First-class Disciple Construction Project of Chinese Material Medical (China)
Zitieren
APA
Liu, J., Zhou, F., Tang, Y., Li, L., & Li, L. (2024). Progress in Lactate Metabolism and Its Regulation via Small Molecule Drugs. Molecules, 29(23), 5656. https://doi.org/10.3390/molecules29235656
Vancouver
Liu J, Zhou F, Tang Y, Li L, Li L. Progress in Lactate Metabolism and Its Regulation via Small Molecule Drugs. Molecules. 2024;29(23):5656. doi:10.3390/molecules29235656
BibTeX
@article{Liu2024,
author = {Liu, Jin and Zhou, Feng and Tang, Yang and Li, Linghui and Li, Ling},
title = {Progress in Lactate Metabolism and Its Regulation via Small Molecule Drugs},
journal = {Molecules},
year = {2024},
volume = {29},
number = {23},
pages = {5656},
doi = {10.3390/molecules29235656}
}
EUVIMED